Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene. 2000 Jul 20; 19(31):3521-8.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Benzamides
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Cell Cycle
Dimethyl Sulfoxide
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Enzyme Inhibitors
Fusion Proteins, bcr-abl
Growth Inhibitors
Hematopoietic Stem Cells
Humans
Imatinib Mesylate
Lung Neoplasms
Megakaryocytes
Mice
Microscopy, Video
Neoplasm Proteins
Phosphorylation
Piperazines
Protein Processing, Post-Translational
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-kit
Pyrimidines
Reactive Oxygen Species
Tumor Cells, Cultured
authors with profiles
Ravi Salgia